Orserdu (elacestrant) is the first treatment for people with ESR1 mutations, which can drive resistance to standard hormone therapy.

The experimental vaccine trains the immune system to recognize HER2 proteins on breast tumors.

Women who received a combination of Kisqali and hormone therapy lived twice as long without their cancer getting worse.

One of the original supermodels of the ’80s and ’90s, Tatjana Patitz also starred in George Michael’s video for “Freedom! ’90.”

Adding an AKT inhibitor to fulvestrant doubled progression-free survival for patients with HR-positive, HER2-negative breast cancer.

How can cancer survivors navigate nutritional treatment obstacles and eat well to support long-term survival?

Advances in immunotherapy, new drug approvals and news about hard-to-treat cancers caught readers’ attention this year.

News stories about celebrities with cancer earned the most views this year, and country music icon Toby Keith reigned.

The latest #ThisIsMBC initiative debuted at SABCS22 and highlights the challenges and hopes of living with metastatic breast cancer.

Differences in the tumor environment may help explain why Black women are more prone to aggressive breast cancer.